Recent Reports


2011-11-14: Biotechnology and Pharmaceuticals Report
5 leading Analysts; and top management from 4 Sector Firms examine this industry.
Order this Report
More Information

2011-10-31: Health Care IT Report
4 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-10-17: Medical Research, Diagnostic Substances & Life Science Tools Report
4 leading Analysts; and top management from 3 Sector Firms examine this industry.
Order this Report
More Information

2011-10-03: Medical Real Estate Report
3 leading Analysts; and top management from 3 Sector Firms examine industry.
Order this Report
More Information

2011-07-11: Medical Devices Report
5 leading Analysts; and top management from 12 Sector Firms examine this industry.
Order this Report
More Information

2011-06-27: Health Care IT Report
6 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

2011-06-13: Medical Research, Diagnostic Substances & Life Science Tools Report
5 leading Analysts; and top management from 3 Sector Firm examine this industry.
Order this Report
More Information

2011-04-04: Biotechnology and Pharmaceuticals Report
3 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-01-24: Medical Devices Report
3 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Analyst Interview Excerpt
OUTLOOK FOR MEDICAL DEVICES & DIAGNOSTICS – DAVID NEXON – ADVANCED MEDICAL TECHNOLOGY ASSOCIATION


Full article published: 03/17/2008


For Subscribers

Get this article online now!

Order just this article
TWST: Let's start with a quick overview of the Advanced Medical Technology Association.
Mr. Nexon: The Advanced Medical Technology Association is the largest association of medical device and diagnostics companies in the United States and I think in the world. We have about 1,300 members and they make 90% of the products sold in the United States and about 50% of the products sold worldwide.

TWST: When you say a medical device, that's a very broad scope.
Mr. Nexon: Yes. The companies we represent make everything from tongue depressors to the most sophisticated MRIs and PET scan machines; they make the cardiac implants, artificial hearts; they develop the diagnostics that make the orthopedic products, the artificial hips and knees; they make wound care products. You name it, if it's used in medicine and it's not a drug, pretty much our companies make it.

TWST: As you look at the field at this point, what's important? What's going on that's kind of changing the face of things at this juncture?
Mr. Nexon: First of all, there is, as you know, a revolution in our basic understanding of biology and the life sciences and that obviously impacts a highly technological very innovative industry like ours. We're producing ever more sophisticated products to deal with the many illnesses that affect humanity. In addition, in the broader context of the health system, there are increased pressures for cost containment in the United States, and we're anticipating a big effort for a sweeping health reform next year. Every country in the world is looking at cost containment issues. So certainly it's important for our industry to make the point that we're not a problem in the medical care system, we're really a part of the solution. It's our products that fuel the medical progress that so many American patients, current and future, hope for and depend on. Worldwide, I think some of the trends that are important are the growth of a number of emerging markets, which are really just in the process of formulating their regulatory and reimbursement systems and working with them at the formative stage is terribly important for the long-term future of the industry. I'm thinking particularly of China and India, but there are other emerging markets around the world too. In terms of volume and sales right now, they're still relatively small, but they're clearly where the future lies.

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.